Kleptose F 7%

Description

KLEPTOSE® F 7% – BETA CYCLODEXTRIN

KLEPTOSE® F 7% – EXP β-cyclodextrin for oral dosage forms contains less than 7% of water. It is well suited for dry processing techniques, such as direct compression, where its low water content benefits moisture-sensitive APIs and formulations (e.g., ODTs, chewables, effervescent tablets) while offering enhanced stability, solubility, and taste masking through molecular encapsulation.

KLEPTOSE® Beta-cyclodextrins

KLEPTOSE® Beta-cyclodextrins are efficient solubilizers, stabilization enhancers and taste-masking agents. A full range is available for use in many dosage forms, from solid to liquid. Molecular encapsulation with beta-cyclodextrins is an accepted and useful tool for pharmaceutical formulators, with many pharmaceutical products containing cyclodextrin complexes on the market. Roquette has developed a wide range of KLEPTOSE® offering features like low water content, various particle size and directly compressible properties with KLEPTOSE® DC.

• Direct Compression
• Encapsulation process versatility
• Superior purity

Roquette has pioneered the industrial development of cyclodextrins with its KLEPTOSE® range of beta-cyclodextrins.

KLEPTOSE® can be used in various oral dosage forms in both pharmaceutical and nutraceutical applications including swallowable tablets, chewable tablets, effervescent tablets, lozenges, hard capsules, soft capsules, orally dissolving films, blends, granules, pellets premix, medicated confectionary, syrups, suspensions and liquids.